Literature DB >> 27606116

Combination of Continuous Dexmedetomidine Infusion with Titrated Ultra-Low-Dose Propofol-Fentanyl for an Awake Craniotomy.

Samaresh Das1, Ali Al-Mashani2, Neelam Suri1, Neeraj Salhotra2, Nilay Chatterjee1.   

Abstract

An awake craniotomy is a continuously evolving technique used for the resection of brain tumours from the eloquent cortex. We report a 29-year-old male patient who presented to the Khoula Hospital, Muscat, Oman, in 2016 with a two month history of headaches and convulsions due to a space-occupying brain lesion in close proximity with the left motor cortex. An awake craniotomy was conducted using a scalp block, continuous dexmedetomidine infusion and a titrated ultra-low-dose of propofolfentanyl. The patient remained comfortable throughout the procedure and the intraoperative neuropsychological tests, brain mapping and tumour resection were successful. This case report suggests that dexmedetomidine in combination with titrated ultra-low-dose propofolfentanyl are effective options during an awake craniotomy, ensuring optimum sedation, minimal disinhibition and a rapid recovery. To the best of the authors' knowledge, this is the first awake craniotomy conducted successfully in Oman.

Entities:  

Keywords:  Anesthesia; Case Report; Craniotomy; Dexmedetomidine; Fentanyl; Oman; Propofol

Year:  2016        PMID: 27606116      PMCID: PMC4996299          DOI: 10.18295/squmj.2016.16.03.014

Source DB:  PubMed          Journal:  Sultan Qaboos Univ Med J        ISSN: 2075-051X


  12 in total

Review 1.  Awake craniotomy: a practice overview.

Authors:  Garry Brydges; Roxanne Atkinson; Monie James Perry; Darline Hurst; Travis Laqua; John Wiemers
Journal:  AANA J       Date:  2012-02

2.  A retrospective analysis of a remifentanil/propofol general anesthetic for craniotomy before awake functional brain mapping.

Authors:  John C Keifer; Dimitar Dentchev; Kenneth Little; David S Warner; Allan H Friedman; Cecil O Borel
Journal:  Anesth Analg       Date:  2005-08       Impact factor: 5.108

3.  Patient satisfaction with awake craniotomy for tumor surgery: a comparison of remifentanil and fentanyl in conjunction with propofol.

Authors:  Pirjo H Manninen; Mrinalini Balki; Karolinah Lukitto; Mark Bernstein
Journal:  Anesth Analg       Date:  2006-01       Impact factor: 5.108

4.  Conscious-sedation analgesia during craniotomy for intractable epilepsy: a review of 354 consecutive cases.

Authors:  D P Archer; J M McKenna; L Morin; P Ravussin
Journal:  Can J Anaesth       Date:  1988-07       Impact factor: 5.063

5.  Comparison of fentanyl, sufentanil and alfentanil during awake craniotomy for epilepsy.

Authors:  E Gignac; P H Manninen; A W Gelb
Journal:  Can J Anaesth       Date:  1993-05       Impact factor: 5.063

Review 6.  The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary.

Authors:  David N Louis; Arie Perry; Guido Reifenberger; Andreas von Deimling; Dominique Figarella-Branger; Webster K Cavenee; Hiroko Ohgaki; Otmar D Wiestler; Paul Kleihues; David W Ellison
Journal:  Acta Neuropathol       Date:  2016-05-09       Impact factor: 17.088

7.  Awake surgery for WHO Grade II gliomas within "noneloquent" areas in the left dominant hemisphere: toward a "supratotal" resection. Clinical article.

Authors:  Yordanka N Yordanova; Sylvie Moritz-Gasser; Hugues Duffau
Journal:  J Neurosurg       Date:  2011-05-06       Impact factor: 5.115

Review 8.  Dexmedetomidine for neurological surgery.

Authors:  Alex Bekker; Mary K Sturaitis
Journal:  Neurosurgery       Date:  2005-07       Impact factor: 4.654

9.  The asleep-awake technique using propofol-remifentanil anaesthesia for awake craniotomy for cerebral tumours.

Authors:  K S Olsen
Journal:  Eur J Anaesthesiol       Date:  2008-02-21       Impact factor: 4.330

10.  Propofol and remifentanil effect-site concentrations estimated by pharmacokinetic simulation and bispectral index monitoring during craniotomy with intraoperative awakening for brain tumor resection.

Authors:  Francisco Lobo; Aldara Beiras
Journal:  J Neurosurg Anesthesiol       Date:  2007-07       Impact factor: 3.956

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.